Now that the patent has expired, generic captopril is available. Sold under the name Captopril tablets, the medication is available in several different strengths, including 12.5 mg, 25 mg, 50 mg, and 100 mg tablets. Different companies currently manufacture generic captopril products, including Sandoz, Teva Pharmaceuticals, and Mylan Laboratories.
Captopril (Capoten®) is a prescription medication that has been licensed to treat high blood pressure (hypertension), congestive heart failure, and diabetic nephropathy, along with improving survival following a heart attack. Captopril is part of a class of drugs called angiotensin-converting enzyme inhibitors, or ACE inhibitors for short. The drug helps to block the angiotensin-converting enzyme, which is normally part of a reaction in the body that causes blood vessels to narrow (constrict). By blocking this enzyme, captopril causes blood vessels to relax, which can lower blood pressure. It also allows the heart to work more efficiently.
Brand-name Capoten was originally developed by Bristol-Myers Squibb Company but is now made by Par Pharmaceutical Companies, Inc. It has since come off-patent, and is now available in a generic form.
Generic captopril is sold under the name Captopril tablets and is available in several strengths, including:
- Captopril 12.5 mg tablets
- Captopril 25 mg tablets
- Captopril 50 mg tablets
- Captopril 100 mg tablets.
Generic captopril is currently manufactured by a number of companies, including:
- Par Pharmaceuticals
- Teva Pharmaceuticals
- Mylan Laboratories